No Data
Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) Stock Price Dropped 3.2% Last Week; Individual Investors Would Not Be Happy
Sichuan Hebang Biotechnology (SHSE:603077) Sheds CN¥642m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
Pinning Down Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) P/E Is Difficult Right Now
Sichuan Hebang Biotechnology (603077.SH): has actually repurchased 0.59% of the company's shares.
On February 6, Glonghui reported that Sichuan Hebang Biotechnology (603077.SH) announced that on February 5, 2025, the company completed the share buyback, having repurchased 51,843,900 shares, accounting for 0.59% of the company's total share capital, with a maximum buyback price of 2.30 yuan/share, a minimum buyback price of 1.88 yuan/share, and an average buyback price of 1.93 yuan/share, utilizing a total of 100,000,056.45 yuan.
Hebang Biotech 2024 Annual Results Pre-Reduction Announcement
Does Sichuan Hebang Biotechnology (SHSE:603077) Have A Healthy Balance Sheet?
Sichuan Hebang Biotechnology (SHSE:603077) Has Some Way To Go To Become A Multi-Bagger
